Bortezomib, adriamycin and dexamethasone for patients with refractory and relapsed myeloma - results from the PAD (Ireland) study

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputMeeting
Volume145
Publication statusPublished - 1 Sep 2009

Cite this